Elekta and RTsafe sign agreement to distribute personalized stereotactic quality assurance solutions
STOCKHOLM, April 19, 2018 – Elekta (EKTA-B.ST) announced today that it has signed a memorandum of understanding with RTsafe to distribute innovative, 3D printed pseudo in-vivo phantoms and remote dosimetry services. The agreement with RTsafe will provide cancer centers an elegant quality assurance (QA) solution by elevating confidence in the end-to-end accuracy of stereotactic systems and create wider access to advanced stereotactic treatments for millions of patients. “Worldwide demand for stereotactic treatments are increasing, especially among the 20 to 40